Meghmani Organics Ltd Q1 FY27 Earnings Call Summary

Event Participants

Executives

1. Ankit Natwarlal Patel — Chairman and Managing Director

Analysts

9. Abhishek Jain, Kriis PMS
10. Ansh Sharma, Individual Investor
11. Harshit Singhania, RoboCapital
12. Love Gupta, Counter Cyclical Investments
13. Mohit Chugh, Subh Labh Research
14. Nachiket Kale, Emkay Global Financial Services
15. Nipun Sharma, VLS Finance
16. N.M. Modi, Individual Investor
17. Rohit Sinha, Sunidhi Securities

Financials & KPIs

Geographic & Segment Commentary

• Crop Protection (75% of revenue): Revenue and EBITDA stood at ₹391 crore and ₹77.8 crore respectively, with an EBITDA margin of 19.9%. Production at 8,880 MT with capacity utilization at ~63%. Management guided for double-digit top-line growth going forward, supported by heavy investment in new registrations and product development. EBITDA margin is expected to remain at or above the 15–17% industry average.

• Pigment Segment (25% of revenue): Revenue and EBITDA stood at ₹131 crore and ₹15.9 crore respectively, with EBITDA margin at 12.1%. Production at 3,233 MT with capacity utilization at just 39% due to soft demand and industry overcapacity. Management guided to a stable ₹500–600 crore annual revenue run-rate, prioritizing profitability (10% EBITDA margin) over top-line expansion. Prior-year tariff impact has now cycled off since April.

• Crop Nutrition: Delivered positive contribution to both revenue and profitability. Added three new nano-based fertilizers—Nano DAP, Nano NPK, Nano Zinc—alongside Nano Urea. Receiving encouraging trial order results in global markets; management expects ₹200+ crore revenue from this segment over the next 2–3 years.

• Titanium Dioxide: Operations remain suspended due to commercial unviability. Sulphur/sulphuric acid raw material prices have surged 8–10x (from ₹4–5 to ₹35–40 range) amid Middle East geopolitical disruptions, while anti-dumping duty protection remains unresolved. Negative EBITDA of ~₹3 crore recorded in Q1; annualized losses expected at ₹10–12 crore if suspension continues.

Company-Specific & Strategic Commentary

• Merger of Wholly-Owned Subsidiaries: Scheme filed in April 2026; second motion application filed after creditor approvals, awaiting next NCLT hearing. Pooling of interest method will consolidate line items into Meghmani Organics Ltd, generating synergies from cost reduction, reduced stocking points, and compliance discipline.

• Nano Fertilizer Expansion: Portfolio expanded from Nano Urea to Nano DAP, Nano NPK, and Nano Zinc, with ongoing approval processes across multiple markets. Investment in developmental activities both domestically and globally expected to drive healthy revenue and profitability growth on a quarter-on-quarter basis.

• Finance Cost Optimization: Shifted debt book to INR-denominated borrowing to eliminate FX MTM volatility; combined with ~₹32 crore quarterly debt repayment (₹130 crore annual target), finance costs are expected to trend lower. No major capex planned for next 1–2 years, enabling continued deleveraging.

• China Tariff Benefit: US tariff imposition on Chinese imports last year adversely impacted Pigment segment; since April 2026, this overhang is gone and demand is picking up gradually.

Guidance & Outlook

Risks & Constraints

Q&A Highlights

Pigment Segment Outlook & Utilization

• Question: With utilization at 39%, will we see better utilization levels or remain under 45–50%? (Rohit Sinha, Sunidhi Securities)
• Answer: Expect utilization to remain in a similar range. Revenue should be ₹550–600 crore annualized. The US tariff hangover on Chinese imports ended April 1, so demand is gradually picking up. Operational efficiency gains over the past year are reducing costs and improving profitability. (Ankit Patel)

Crop Protection Growth and Margin Guidance

• Question: How should we model Crop Protection volumes and margins going forward? (Rohit Sinha, Sunidhi Securities)
• Answer: Very optimistic on 2–3 year growth driven by heavy investment in new registrations and product development. Expect double-digit top-line growth with healthy bottom-line improvement. Minor macro disruptions possible in one or two quarters. (Ankit Patel)

Nano Fertilizer Revenue Potential

• Question: What is the current Nano Urea sales volume and future revenue contribution? (Nipun Sharma, VLS Finance)
• Answer: Can't disclose volumes but growth is healthy in both domestic and global markets. Three new products added (Nano DAP, Nano NPK, Nano Zinc). Targeting ₹200+ crore revenue from Nano Fertilizer segment over next 2–3 years. (Ankit Patel)

Revenue Quality and Pricing vs Volume Bifurcation

• Question: How much of the 12% revenue decline was volume vs pricing, and which geography contributed most? (Mohit Chugh, Subh Labh Research)
• Answer: Volume declined ~17% YoY; focus was on profitability rather than top-line. Latin America was the primary contributor to the decline, driven by pricing pressure from input cost inflation. Company deliberately avoided pushing volume where realization was unfavorable, shifting to higher-margin products and markets. (Ankit Patel)

Titanium Dioxide Resumption Conditions

• Question: What is required for TiO2 operations to resume? (Ansh Sharma, Individual Investor)
• Answer: Two conditions must be met: (1) raw material prices normalizing — sulphur has moved from ₹4–5 to ₹35–40 range, an 8–10x increase driven by Middle East conflict, and (2) anti-dumping duty reinstatement. Currently no improvement on either front; operations will remain suspended until then. (Ankit Patel)

Finance Cost Reduction Drivers

• Question: What contributed to the substantial finance cost reduction, and is it sustainable? (N.M. Modi, Individual Investor)
• Answer: Two factors: (1) shifted debt to INR-denominated borrowings, eliminating FX MTM losses that hit prior quarters, and (2) continued debt repayment — ₹32 crore in Q1 with ~₹130 crore targeted for FY27. With no major capex for 1–2 years, debt will continue reducing as earnings grow. (Ankit Patel)

Consolidated Margin Mathematics

• Question: With Crop Protection at 15–17% and Pigment at ~10%, should consolidated margins be ~15–16%? (Abhishek Jain, Kriis PMS)
• Answer: No — 15–16% overall is too high. Consolidated EBITDA margin will be in the 12–13% range after accounting for other segments including the suspended TiO2 operations. (Ankit Patel)

Pigment Margin Sustainability

• Question: Can we sustain the 12% Pigment EBITDA margin seen in Q1? (Nachiket Kale, Emkay Global)
• Answer: Top-line of ₹500–600 crore is maintainable. Bottom-line will fluctuate with plus/minus variance, but management targets ~10% EBITDA margin for the segment on a sustainable basis. (Ankit Patel)

Industry Consolidation in Pigments

• Question: Are we seeing consolidation in the pigment industry given the inflationary environment? (Love Gupta, Counter Cyclical Investments)
• Answer: Some companies have reduced capacity to balance supply-demand, which helps pricing. However, this is a stagnant industry and no significant M&A or consolidation activity is occurring. (Ankit Patel)

Key Takeaway

Meghmani Organics delivered a mixed Q1 FY27: consolidated revenue declined 12% YoY to ₹542 crore on a 17% volume drop, but consolidated net profit surged 280% to ₹48.2 crore with EBITDA up 46% to ₹97.9 crore, reflecting a concentrated shift toward profitability over volume growth. Crop Protection remains the earnings engine with a 19.9% segment EBITDA margin, while Pigment segment margins improved from 3% to 12.1% driven by better realization and operational efficiencies. Management's strategic priorities include expanding the Nano Fertilizer portfolio (Nano DAP, Nano NPK, Nano Zinc added alongside Nano Urea, targeting ₹200+ crore in 2–3 years), executing the NCLT-approved amalgamation of wholly-owned subsidiaries for cost synergies, and aggressive deleveraging (₹130 crore annual debt repayment, shifting to INR-denominated borrowings to eliminate FX MTM volatility). Guidance points to double-digit Crop Protection top-line growth, ₹500–600 crore Pigment revenue at ~10% EBITDA margin, and 12–13% consolidated EBITDA margins, with TiO2 resumption contingent on normalization of sulphur prices (currently 8–10x historical levels) and anti-dumping duty reinstatement — both uncertain. Management remains optimistic on 2–3 year structural growth driven by new product registrations and geographic diversification, despite near-term macroeconomic volatility.